Product Information
CABERGOLINE 0.5 MG TABLET is a generic product labeled by Somerset Therapeutics, LLC, priced at $1.2952 per EA under NDC 70069082408. Its NADAC has been published 84 times since Feb 26, 2025.
FDA first approved this application on Sep 9, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Somerset Therapeutics, LLCNDC
70069082408
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CABERGOLINEApproval Type
Generic (ANDA)
FDA Application
ANDA218109FDA Approved
9/9/2024
TE Code
AB
On Market Since
10/18/2024
Pharmacological Classes
Price Statistics
The NADAC for CABERGOLINE 0.5 MG TABLET has been published 84 times since Feb 26, 2025, and over the history we have for it it has declined 12.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2952 per EA |
|---|---|
| All-time high | $1.6393 (Jun 11, 2025) |
| All-time low | $1.2952 (Sep 23, 2026) |
| 52-week high | $1.5270 |
| 52-week low | $1.2952 |
| Median price | $1.4593 |
| Average price | $1.4729 |
| Largest weekly change | +9.1% (Mar 19, 2025) |
| Weeks tracked | 84 |
| Tracking since | Feb 26, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CABERGOLINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Somerset Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CABERGOLINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Ergot Derivative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CABERGOLINE 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CABERGOLINE 0.5 MG TABLET, manufactured by Somerset Therapeutics, LLC, is $1.2952 per EA (NDC 70069082408), effective Sep 30, 2026.
How has the price of CABERGOLINE 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CABERGOLINE 0.5 MG TABLET has declined 12.4%. It has been tracked across 84 weekly CMS publications since Feb 26, 2025.
What are the highest and lowest recorded NADAC prices for CABERGOLINE 0.5 MG TABLET?
Since Feb 26, 2025, the NADAC for CABERGOLINE 0.5 MG TABLET has ranged from a low of $1.2952 (Sep 23, 2026) to a high of $1.6393 (Jun 11, 2025), with a median of $1.4593 per EA.
Are there cheaper alternatives to CABERGOLINE 0.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CABERGOLINE 0.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CABERGOLINE 0.5 MG TABLET?
CABERGOLINE 0.5 MG TABLET (NDC 70069082408) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.